10x genomics comments on second upc preliminary injunction decision

Upc denies second preliminary injunction request; prior injunctions against nanostring's cosmx products in europe remain in full effect pleasanton, calif. , oct. 10, 2023 /prnewswire/ -- 10x genomics, inc. (nasdaq: txg), a leader in single cell and spatial biology, announced today that the european unified patent court ("upc") has declined to issue a second preliminary injunction against nanostring technologies, inc. (nasdaq: nstg) based on european patent 2 794 928 b1 ("the ep 928 patent," docket no 459996/2023).
NSTG Ratings Summary
NSTG Quant Ranking